These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 28918288)

  • 21. IL-15 induces strong but short-lived tumor-infiltrating CD8 T cell responses through the regulation of Tim-3 in breast cancer.
    Heon EK; Wulan H; Macdonald LP; Malek AO; Braunstein GH; Eaves CG; Schattner MD; Allen PM; Alexander MO; Hawkins CA; McGovern DW; Freeman RL; Amir EP; Huse JD; Zaltzman JS; Kauff NP; Meyers PG; Gleason MH; Overholtzer MG; Wiseman SS; Streutker CD; Asa SW; McAlindon TP; Newcomb PO; Sorensen PM; Press OA
    Biochem Biophys Res Commun; 2015 Aug; 464(1):360-6. PubMed ID: 26141233
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A deleterious role for Th9/IL-9 in hepatic fibrogenesis.
    Qin SY; Lu DH; Guo XY; Luo W; Hu BL; Huang XL; Chen M; Wang JX; Ma SJ; Yang XW; Jiang HX; Zhou Y
    Sci Rep; 2016 Jan; 6():18694. PubMed ID: 26728971
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intensified Th9 Response is Associated with the Immunopathogenesis of Active Ulcerative Colitis.
    Shohan M; Sabzevary-Ghahfarokhi M; Bagheri N; Shirzad H; Rahimian G; Soltani A; Ghatreh-Samani M; Deris F; Tahmasbi K; Shahverdi E; Fathollahi F
    Immunol Invest; 2018 Oct; 47(7):700-711. PubMed ID: 29927662
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Class I- and class II-reactive TCRs coexpressed on CD4+ T cells both trigger CD4/CD8-shared and CD4-unique functions.
    Asnagli H; Schmitt-Verhulst AM; Guimezanes A
    J Immunol; 1997 May; 158(10):4533-42. PubMed ID: 9144464
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Th9 cells, new players in adaptive immunity.
    Schmitt E; Klein M; Bopp T
    Trends Immunol; 2014 Feb; 35(2):61-8. PubMed ID: 24215739
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Th9 Cells Represent a Unique Subset of CD4
    Lu Y; Wang Q; Xue G; Bi E; Ma X; Wang A; Qian J; Dong C; Yi Q
    Cancer Cell; 2018 Jun; 33(6):1048-1060.e7. PubMed ID: 29894691
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Th9 Cells: New Member of T Helper Cell Family.
    Goswami R
    Methods Mol Biol; 2017; 1585():1-19. PubMed ID: 28477183
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determining the Frequencies of Th9 Cells from Whole Blood.
    Rajamanickam A; Babu S
    Methods Mol Biol; 2017; 1585():83-92. PubMed ID: 28477189
    [TBL] [Abstract][Full Text] [Related]  

  • 29. From interleukin-9 to T helper 9 cells.
    Stassen M; Schmitt E; Bopp T
    Ann N Y Acad Sci; 2012 Jan; 1247():56-68. PubMed ID: 22235761
    [TBL] [Abstract][Full Text] [Related]  

  • 30. T
    Clark RA; Schlapbach C
    Semin Immunopathol; 2017 Jan; 39(1):47-54. PubMed ID: 27896634
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IL-9 and Th9 Cells in Tumor Immunity.
    He Y; Dong L; Cao Y; Bi Y; Liu G
    Adv Exp Med Biol; 2020; 1240():35-46. PubMed ID: 32060886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IL-4 together with IL-1β induces antitumor Th9 cell differentiation in the absence of TGF-β signaling.
    Xue G; Jin G; Fang J; Lu Y
    Nat Commun; 2019 Mar; 10(1):1376. PubMed ID: 30914642
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TNF superfamily cytokines in the promotion of Th9 differentiation and immunopathology.
    Meylan F; Siegel RM
    Semin Immunopathol; 2017 Jan; 39(1):21-28. PubMed ID: 27896636
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exposure to particulate matter 2.5 (PM2.5) induced macrophage-dependent inflammation, characterized by increased Th1/Th17 cytokine secretion and cytotoxicity.
    Ma QY; Huang DY; Zhang HJ; Wang S; Chen XF
    Int Immunopharmacol; 2017 Sep; 50():139-145. PubMed ID: 28654841
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of human Th9 differentiation by type I interferons and IL-21.
    Wong MT; Ye JJ; Alonso MN; Landrigan A; Cheung RK; Engleman E; Utz PJ
    Immunol Cell Biol; 2010 Aug; 88(6):624-31. PubMed ID: 20421880
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expansion of Tumor-reactive T Cells From Patients With Pancreatic Cancer.
    Meng Q; Liu Z; Rangelova E; Poiret T; Ambati A; Rane L; Xie S; Verbeke C; Dodoo E; Del Chiaro M; Löhr M; Segersvärd R; Maeurer MJ
    J Immunother; 2016; 39(2):81-9. PubMed ID: 26849077
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polarizing Cytokines for Human Th9 Cell Differentiation.
    Putheti P
    Methods Mol Biol; 2017; 1585():73-82. PubMed ID: 28477188
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interleukin-35 Suppresses the Antitumor Activity of T Cells in Patients with Non-Small Cell Lung Cancer.
    Wang HM; Zhang XH; Feng MM; Qiao YJ; Ye LQ; Chen J; Fan FF; Guo LL
    Cell Physiol Biochem; 2018; 47(6):2407-2419. PubMed ID: 29991058
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Th9 cells: a novel CD4 T-cell subset in the immune war against cancer.
    Végran F; Apetoh L; Ghiringhelli F
    Cancer Res; 2015 Feb; 75(3):475-9. PubMed ID: 25589348
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The transcription factor network in Th9 cells.
    Kaplan MH
    Semin Immunopathol; 2017 Jan; 39(1):11-20. PubMed ID: 27837254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.